» Articles » PMID: 12595561

Protein Concerted Motions in the DNA-human Topoisomerase I Complex

Overview
Specialty Biochemistry
Date 2003 Feb 22
PMID 12595561
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The collective motions of the core and C-terminal domains of human topoisomerase I (topo I) have been analysed by molecular dynamics simulation of the protein in covalent complex with a 22 bp DNA duplex. The analysis evidenced a great number of correlated movements of core subdomain I and II residues, and a central role for helix 5 in the protein-DNA communication, in particular with the scissile strand downstream of the cleavage site. The flow of information between these core subdomains and DNA suggests that subdomains I and II play an essential role in the DNA relaxation process. In core subdomain III the majority of DNA contacting residues do not communicate with protein regions far from DNA, suggesting that they have a structural role. However, selected core subdomain III residues, involved in the orientation of the active site region, show correlated movements with residues distant from DNA, indicating that the information concerning the catalytic event is also transmitted. The flexibility of two loops formed by residues 519-520 and 580-584 seems indispensable to the dynamic participation of core subdomain III to the DNA cleavage and religation steps. The motion of specific residues has also been found to explain the effect of single point mutations that make topo I resistant to the anticancer drug camptothecin.

Citing Articles

Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors.

Mohamed M, Elsaman T, Elderdery A, Alsrhani A, Ghanem H, Alruwaili M Int J Mol Sci. 2024; 25(19).

PMID: 39409108 PMC: 11476810. DOI: 10.3390/ijms251910779.


Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B.

Ottaviani A, Iacovelli F, Welsch J, Morozzo Della Rocca B, Desideri A, Falconi M Cells. 2022; 11(21).

PMID: 36359884 PMC: 9654473. DOI: 10.3390/cells11213486.


From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge .

Ottaviani A, Welsch J, Agama K, Pommier Y, Desideri A, Baker B J Enzyme Inhib Med Chem. 2022; 37(1):1404-1410.

PMID: 35603503 PMC: 9132426. DOI: 10.1080/14756366.2022.2078320.


Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states.

Takahashi D, Gadelle D, Agama K, Kiselev E, Zhang H, Yab E Nat Commun. 2022; 13(1):59.

PMID: 35013228 PMC: 8748870. DOI: 10.1038/s41467-021-27686-7.


In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.

Soren B, Dasari J, Ottaviani A, Messina B, Andreotti G, Romeo A Int J Mol Sci. 2021; 22(14).

PMID: 34299074 PMC: 8306514. DOI: 10.3390/ijms22147455.


References
1.
Cheatham 3rd T, Kollman P . Molecular dynamics simulation of nucleic acids. Annu Rev Phys Chem. 2000; 51:435-71. DOI: 10.1146/annurev.physchem.51.1.435. View

2.
Castrignano T, Chillemi G, Desideri A . Structure and hydration of BamHI DNA recognition site: a molecular dynamics investigation. Biophys J. 2000; 79(3):1263-72. PMC: 1301022. DOI: 10.1016/S0006-3495(00)76380-6. View

3.
Chillemi G, Falconi M, Amadei A, Zimatore G, Desideri A, Di Nola A . The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication. Biophys J. 1997; 73(2):1007-18. PMC: 1180998. DOI: 10.1016/S0006-3495(97)78134-7. View

4.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

5.
Fiorani P, Amatruda J, Silvestri A, Butler R, Bjornsti M, Benedetti P . Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Mol Pharmacol. 1999; 56(6):1105-15. DOI: 10.1124/mol.56.6.1105. View